Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Serotonin Syndrome × NET × Clear all

Phase

Status

Completed 6 Terminated 2 Withdrawn 1 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 3 NET 1

Conditions

Neuroendocrine Tumors 17 Carcinoid Tumor 5 Pheochromocytoma 3 Vipoma 2 Paraganglioma 2 Neoplasms 2 Insulinoma 2 Gastro-enteropancreatic neuroendocrine tumor 2 Carcinoma, Merkel Cell 2 Zollinger-Ellison Syndrome 1 Somatostatinoma 1 Small Cell Lung Carcinoma 1 Serotonin Syndrome 1 Pancreatic Neoplasms 1 Non functioning pancreatic endocrine tumor 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Neoplasms, Cystic, Mucinous, and Serous 1 Multiple Endocrine Neoplasia Type 2b 1 Multiple Endocrine Neoplasia Type 2a 1 Multiple Endocrine Neoplasia Type 1 1 Lung Neoplasms 1 Liver Neoplasms 1 Hypoglycemia 1 Glucagonoma 1 Gastrinoma 1 Diarrhea 1 Carcinoma, Medullary 1 Cachexia 1 Adrenal Gland Neoplasms 1

Interventions

telotristat ethyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04713202 2023-02-10

NET-PACS

Big Ten Cancer Research Consortium

Phase 2 Withdrawn

Diarrhea, Neuroendocrine Tumors, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡